Role of Herbal Based Mouthwashes in Plaque Control

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorAjman University

About this trial

Herbal medicine has been used for thousands of years. Traditional herbal medicine is used by an estimated 80% of the world's population for primary health care. Herbal treatments have gained popularity as a dietary supplement for illness prevention and as an alternative/complementary therapy in recent years. Herbal remedies come in a wide variety of forms and can be found on the market all over the world.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients who are medically fit

Patients with gingival inflammation not progressed into periodontitis (AAP classification

Patients between the age of 18-60 years

Disqualifiers

Patients who are medically compromised

Patient who have undergone a periodontal therapy for the past 3 months

Patients who are healthy but have been using herbal mouthwashes

Trial design

Design model

Parallel

Treatments tested in this trial

  • Mouthwash Product

    Other intervention

    * In the Initial Visit-Baseline, and subsequent visits, participants will be called in the morning. Morning hours will be chosen for examination, as it will reduce the risk of bias and also help in quantifying results. plaque and gingival scores will be recorded and the First herbal mouthwashes will be given, participants will also be provided new tooth-brushes (Oral B-soft). * They will be asked to follow their routine oral hygiene habits. They will be asked to come back after 2 weeks for plaque and gingival bleeding scores recording for the second visit and again after 2weeks post the second visit for the third and final visit to record their plaque and gingival bleeding scores.

Treatment groups

80 Participants
are divided into 4 treatment groups
Group A: chlorhexidineExperimental treatment 1 intervention
Group B: Tea tree oilActive comparator 1 intervention
Group C: ReseverotriolActive comparator 1 intervention
Group D: MiswakActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

plaque score

To assess the plaque score

Time frame
From Baseline-pre-intervention to the end of treatment at 4 weeks

Secondary outcomes

1

gingival bleeding score

To assess gingival bledding score

Time frame
from pre-intervention to the end of the treatment at 4 weeks

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: